"At ICML, Agnieszka Podsiadło and I are sharing some of what we're building at Isomorphic Labs: Methods that can generalise drug discovery - finding new biology, at scale and across pretty much every therapeutic modality. That last part matters to me most - it's how you get to a place where no patient is left behind." - Andreas Loukas, AI research scientist.If you're in Seoul this week, come say hi to Andreas - @loukasa_tweet and the rest of our delegation at ICML. ...